Publications by authors named "Rachel K Russ"
This prospective study enrolled healthcare workers (HCWs) who were nonresponders following at least 5 doses of aluminum-adjuvanted hepatitis B vaccine who received the 2-dose Heplisav-B (HepB-CpG) (Dynavax Technologies Corporation, Emeryville, CA) series. After 2 doses of HepB-CpG, 43/47 (91%) participants, and with 1 dose, 41/49 (84%) responded. HepB-CpG could be the preferred vaccine in HCW nonresponders.
View Article and Find Full Text PDFArticle Synopsis
- A study was conducted to investigate racial, ethnic, and geographic disparities in influenza vaccine uptake among adults with inflammatory bowel disease (IBD) across two medical centers.
- The findings revealed that non-Hispanic White patients and older individuals were more likely to receive the influenza vaccine, while Black patients and those from underserved areas had lower vaccination rates.
- The research highlighted the need for further studies to explore ways to improve vaccination rates and address these disparities amongst IBD patients.
Cross-sectional study of coronavirus disease 2019 (COVID-19) vaccine uptake among healthcare workers.
Antimicrob Steward Healthc Epidemiol
April 2022
High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
July 2022
Coronavirus disease 2019 (COVID-19) vaccines are recommended for all patients with inflammatory bowel disease (IBD). Patients with IBD historically have had low vaccine uptake relative to the general population. However, a recent survey suggested a rate higher than that of the general population with regard to COVID-19 vaccine intent among the IBD population.
View Article and Find Full Text PDF